Clinical, biochemical profile and atherosclerotic cardiovascular risk score (ASCVD) in patients with high HDL cholesterol

被引:0
|
作者
Mallya, Raksha Udupi [1 ]
Vidyasagar, Sudha [1 ]
Varashree, B. S. [2 ]
Sukumar, Cynthia Amrutha [1 ]
机构
[1] Manipal Acad Higher Educ, Kasturba Med Coll, Dept Gen Med, Manipal 576104, Karnataka, India
[2] Manipal Acad Higher Educ, Kasturba Med Coll, Dept Biochem, Manipal 576104, Karnataka, India
关键词
ASCVD; CETP; HDL cholesterol; Lipidology; METs; CORONARY-HEART-DISEASE; ALCOHOL-CONSUMPTION; ATHEROGENIC DYSLIPIDEMIA; HYPERTENSION; POPULATION; JAPANESE; GENE;
D O I
10.1007/s11845-025-03878-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundIt was observed that many people in the western coastal belt were found to have a high HDL cholesterol, the cause of which was not known. This study was done to learn about the factors contributing to the high HDL cholesterol in these patients and its effect on ASCVD risk.MethodsIn this prospective, case control study, 150 patients were recruited, of which 63 were cases (patients with high HDL cholesterol), and 87 were controls (patients with normal HDL cholesterol). Details regarding their diet, sea-food consumption, habits, comorbidities, daily activity (using GPAQ questionnaire), and blood reports were collected. ASCVD risk score was calculated using an online ASCVD risk estimator. Blood samples of 96 patients (cases 40, controls 56) was tested for cholesterol esterase transfer protein (CETP) levels using ELISA, and the results were compared.ResultsPatients with high HDL cholesterol were found to be physically more active and had median metabolic equivalent (METs) of 4680 (1200, 8580) compared with controls with median METs of 1680 (720, 5580), P-0.013. Cases had a lower mean BMI 23.09(SD-3.69), than in patients with normal HDL cholesterol with a mean of 24.41(SD-4.01), P-0.04. Cases also had a lower triglyceride level (91(69,118) in cases vs 121 (80,151) in controls, P-0.002. Alcohol and sea food consumption had no role on HDL levels in this study. The median CETP level was lower in patients with high HDL levels, 0.336(0.08, 0.336) versus 1.435(0.061, 2.893) in the control group although not statistically significant. Patients with high HDL cholesterol were found to have a significantly lower median 10-year ASCVD risk score 3.05 (0.6, 8.95), compared with patients with normal HDL 6.45 (2.7,14.2).ConclusionPatients with high HDL cholesterol were found to be physically more active, had a lower BMI, a lower triglyceride level, and a lower ASCVD risk compared with controls. They also had a lower CETP level. Further research will be required to determine the normal CETP level in Indian population, their genetic makeup, and whether it has a role in cardiovascular protection.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Long-term validation of AtherosSlerosis CardioVascular Disease (ASCVD) risk score and the role of aspirin for primary Cardiovascular prevention in Korean patients with over ASCVD 20% risk score
    Rha, S.
    Hyun, S.
    Choi, B. G.
    Choi, S. Y.
    Cha, J.
    Kang, J.
    Chu, W.
    Park, S.
    Choi, C. U.
    Park, C. G.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [22] REDUCED RISK PROFILE FOR ATHEROSCLEROTIC CARDIOVASCULAR-DISEASE (ASCVD) IN HIGHLY TRAINED SENIOR ATHLETES (SA)
    DRINKWATER, D
    LAKATTA, L
    BUSBY, J
    COON, P
    BANNON, M
    FLEG, J
    GOLDBERG, A
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1986, 34 (12) : 911 - 911
  • [23] Long-term validation of AtherosSlerosis CardioVascular Disease (ASCVD) risk score and the role of aspirin for primary Cardiovascular prevention in Korean patients with over ASCVD 20% risk score
    Rha, S.
    Hyun, S.
    Choi, B. G.
    Choi, S. Y.
    Cha, J.
    Kang, J.
    Chu, W.
    Park, S.
    Choi, C. U.
    Park, C. G.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [24] Clinical potential of inclisiran for patients with a high risk of atherosclerotic cardiovascular disease
    Toshiyuki Nishikido
    Cardiovascular Diabetology, 22
  • [25] Clinical potential of inclisiran for patients with a high risk of atherosclerotic cardiovascular disease
    Nishikido, Toshiyuki
    CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [26] Management of the Heightened Risk for Clinical Events from Atherosclerotic Cardiovascular Disease (ASCVD) in an Established Cohort of Lupus Erythematosus Patients
    Zhao, Megan
    Williams, Kevin
    Jacoby, Douglas
    Feng, Rui
    Werth, Victoria
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 2932 - 2934
  • [27] Apolipoprotein B, Non-HDL Cholesterol, and LDL Cholesterol as Markers for Atherosclerotic Cardiovascular Disease Risk Assessment
    Yun, Yeo-Min
    ANNALS OF LABORATORY MEDICINE, 2023, 43 (03) : 221 - 222
  • [28] High cholesterol absorption: A risk factor of atherosclerotic cardiovascular diseases?
    Simonen, Piia
    Oorni, Katariina
    Sinisalo, Juha
    Strandberg, Timo E.
    Wester, Ingmar
    Gylling, Helena
    ATHEROSCLEROSIS, 2023, 376 : 53 - 62
  • [29] Management of the heightened risk for clinical events from atherosclerotic cardiovascular disease (ASCVD) in an established cohort of lupus erythematosus patients
    Zhao, M.
    Williams, K. J.
    Jacoby, D.
    Feng, R.
    Werth, V.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (08) : S25 - S25
  • [30] Cardiovascular risk assessment after continuing or switching to a doravirine-based regimen using the atherosclerotic cardiovascular disease (ASCVD) risk score model
    Hsue, P.
    Behrens, G.
    Xu, Z. J.
    Zhao, Y.
    Cmar, J.
    Lahoulou, R.
    Campo, R.
    Plank, R. M.
    HIV MEDICINE, 2023, 24 : 259 - 262